Related content

Issues to debate on the Women’s Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma?

By Machens K.   Schmidt‐Gollwitzer K.  

Human Reproduction, Vol. 18, Iss. 10, 2003-10 ,pp. : 1992-1999

Oxford University Press

Access to resources Recommend Favorite

Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials—time out for hormone replacement therapy studies?

By Pedersen Anette Tønnes   Ottesen Bent  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2241-2244

Oxford University Press

Access to resources Recommend Favorite

The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women

By Genazzani Andrea R.   Gambacciani Marco   Simoncini Tommaso  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 183-185

Informa Healthcare

Access to resources Recommend Favorite

Puberty, ageing and hormone replacement therapy. Health profile of middle-aged women: The Women's Health in the Lund Area (WHILA) study

By Li Cairu  

Human Reproduction, Vol. 17, Iss. 5, 2002-05 ,pp. : 1379-1385

Oxford University Press

Access to resources Recommend Favorite

The comparison of bleeding patterns with high-dose and low-dose hormone replacement therapy in postmenopausal women

By Kazerooni T   Zolghadri J  

Gynecological Endocrinology, Vol. 19, Iss. 2, 2004-08 ,pp. : 64-68

Informa Healthcare

Access to resources Recommend Favorite